Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 341-350 of 2915 for cancer

Edit search filters
  1. LEGEND Study: EG-70 In NMIBC Patients BCG-Unresponsive And High-Risk NMIBC Incompletely Treated With BCG Or BCG-Naïve

    Scottsdale/Phoenix, AZ, Rochester, MN

  2. Standard Or Comprehensive Radiation Therapy In Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy And Surgery

    Albert Lea, MN, Jacksonville, FL, La Crosse, WI, Mankato, MN, Rochester, MN

  3. PLX038 For The Treatment Of Metastatic Ovarian, Peritoneal, And Fallopian Tube Cancers

    Rochester, MN

  4. Adaptive Therapy With Capecitabine For Treatment Of Metastatic ER Positive, HER2 Negative Breast Cancer

    Scottsdale/Phoenix, AZ

  5. Novel HSF1 Pathway Inhibitor NXP800 In Patients With Advanced Cholangiocarcinoma

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  6. A Phase 1 Study Of The Safety And Tolerability Of MT-125 In GBM Patients

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  7. The BEACON Study (Breast Cancer Outcomes With NKTR-102)

    Jacksonville, FL, Rochester, MN

  8. Study Comparing Tarlatamab And Durvalumab Versus Durvalumab Alone In First-Line Extensive-Stage Small-Cell Lung Cancer (ES-SCLC) Following Platinum, Etoposide And Durvalumab (DeLLphi-305)

    Rochester, MN

  9. ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063D

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  10. A Study To Evaluate Hyperthermic Intraperitoneal Chemotherapy To Treat Patients With Pancreatic Cancer And Peritoneal Metastasis

    Rochester, MN

.

Mayo Clinic Footer